Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Generation Bio Stock

Q: How to sell Generation Bio stock?

If you hold private company shares of Generation Bio - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Generation Bio stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

generationbio.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $125.37MM

Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases.

Buy or sell Generation Bio stockLearn more about Generation Bio IPO

OverviewFinancingsValuation

Enterprise Value

Access Generation Bio’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Generation Bio.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Thomas Graney

Chief Financial Officer

Will McCarthy

Chief Business Officer

Jason Rhodes

Chairman & Co-Founder

Mark Angelino Ph.D

Chief Operating Officer & Co-Founder

Robert Kotin Ph.D

Co-Founder & Head of Discovery

Geoffrey McDonough MD

Chief Executive Officer, President & Board Member

Jennifer Elliott Ph.D

Vice President, Head of Legal Affairs and Intellectual Property

Board Members

Donald Nicholson Ph.D

Anthony Quinn Ph.D

Geoffrey McDonough MD

Gustav Christensen

Jeffrey Jonas MD

Catherine Stehman-Breen MD

Jason Rhodes

Generation Bio stock FAQs

Can you buy Generation Bio stock?

As Generation Bio is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Generation Bio, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Generation Bio stock?

To invest in a private company like Generation Bio through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Generation Bio stock?

Yes, you may be able to sell your Generation Bio stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Generation Bio stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Generation Bio stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Generation Bio a public company?

No, Generation Bio is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Generation Bio’s stock price?

Generation Bio is a privately held company and therefore does not have a public stock price. However, you may access Generation Bio’s private market stock price with Forge Data.

What is Generation Bio’s stock ticker symbol?

Generation Bio does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Xconomy 01/13/2020

Xconomy: Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans

JP Morgan’s annual healthcare conference convenes in San Francisco this week and Generation Bio CEO Geoff McDonough is betting gene therapy will be among

FINSMES 01/10/2020

Generation Bio Raises $110M in Series C Financing | FinSMEs

Generation Bio, a Cambridge, MA-based gene therapy company, closed a $110m Series C financing. round led by T. Rowe Price funds and accounts

Business Wire 10/29/2019

Generation Bio Welcomes Steven Dowdy, Ph.D., to its Scientific Advisory Board

Generation Bio announced that Steven Dowdy, Ph.D., has joined its Scientific Advisory Board.

Scrip 03/05/2018

Venture Funding Deals: Celularity Launches With $250m; Generation Bio Grabs $100m Series B

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.